14-67143410-T-C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_020806.5(GPHN):​c.1797T>C​(p.Asp599Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0042 in 1,610,834 control chromosomes in the GnomAD database, including 33 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0031 ( 1 hom., cov: 31)
Exomes 𝑓: 0.0043 ( 32 hom. )

Consequence

GPHN
NM_020806.5 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 1.53

Publications

4 publications found
Variant links:
Genes affected
GPHN (HGNC:15465): (gephyrin) This gene encodes a neuronal assembly protein that anchors inhibitory neurotransmitter receptors to the postsynaptic cytoskeleton via high affinity binding to a receptor subunit domain and tubulin dimers. In nonneuronal tissues, the encoded protein is also required for molybdenum cofactor biosynthesis. Mutations in this gene may be associated with the neurological condition hyperplexia and also lead to molybdenum cofactor deficiency. Numerous alternatively spliced transcript variants encoding different isoforms have been described; however, the full-length nature of all transcript variants is not currently known. [provided by RefSeq, Jul 2008]
GPHN Gene-Disease associations (from GenCC):
  • sulfite oxidase deficiency due to molybdenum cofactor deficiency type C
    Inheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics, ClinGen
  • hereditary hyperekplexia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.47).
BP6
Variant 14-67143410-T-C is Benign according to our data. Variant chr14-67143410-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 466203.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.53 with no splicing effect.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.0031 (472/152276) while in subpopulation SAS AF = 0.00644 (31/4816). AF 95% confidence interval is 0.00486. There are 1 homozygotes in GnomAd4. There are 230 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 32 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GPHNNM_020806.5 linkc.1797T>C p.Asp599Asp synonymous_variant Exon 18 of 23 ENST00000478722.6 NP_065857.1 Q9NQX3-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GPHNENST00000478722.6 linkc.1797T>C p.Asp599Asp synonymous_variant Exon 18 of 23 1 NM_020806.5 ENSP00000417901.1 Q9NQX3-2

Frequencies

GnomAD3 genomes
AF:
0.00310
AC:
471
AN:
152158
Hom.:
1
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.000724
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00229
Gnomad ASJ
AF:
0.00115
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00643
Gnomad FIN
AF:
0.000377
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00531
Gnomad OTH
AF:
0.00287
GnomAD2 exomes
AF:
0.00379
AC:
954
AN:
251406
AF XY:
0.00431
show subpopulations
Gnomad AFR exome
AF:
0.000800
Gnomad AMR exome
AF:
0.00119
Gnomad ASJ exome
AF:
0.00149
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.000370
Gnomad NFE exome
AF:
0.00509
Gnomad OTH exome
AF:
0.00277
GnomAD4 exome
AF:
0.00432
AC:
6298
AN:
1458558
Hom.:
32
Cov.:
27
AF XY:
0.00441
AC XY:
3203
AN XY:
725794
show subpopulations
African (AFR)
AF:
0.000658
AC:
22
AN:
33422
American (AMR)
AF:
0.00130
AC:
58
AN:
44714
Ashkenazi Jewish (ASJ)
AF:
0.00157
AC:
41
AN:
26114
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39678
South Asian (SAS)
AF:
0.00999
AC:
861
AN:
86188
European-Finnish (FIN)
AF:
0.000524
AC:
28
AN:
53408
Middle Eastern (MID)
AF:
0.00174
AC:
10
AN:
5762
European-Non Finnish (NFE)
AF:
0.00461
AC:
5117
AN:
1108986
Other (OTH)
AF:
0.00267
AC:
161
AN:
60286
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
310
621
931
1242
1552
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
174
348
522
696
870
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00310
AC:
472
AN:
152276
Hom.:
1
Cov.:
31
AF XY:
0.00309
AC XY:
230
AN XY:
74464
show subpopulations
African (AFR)
AF:
0.000722
AC:
30
AN:
41570
American (AMR)
AF:
0.00229
AC:
35
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00115
AC:
4
AN:
3466
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5174
South Asian (SAS)
AF:
0.00644
AC:
31
AN:
4816
European-Finnish (FIN)
AF:
0.000377
AC:
4
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00531
AC:
361
AN:
68012
Other (OTH)
AF:
0.00284
AC:
6
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
22
43
65
86
108
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00394
Hom.:
2
Bravo
AF:
0.00317
Asia WGS
AF:
0.00202
AC:
7
AN:
3478
EpiCase
AF:
0.00409
EpiControl
AF:
0.00450

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Sep 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

GPHN: BP4, BS2 -

Sep 24, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C;C4551954:Hyperekplexia 1 Benign:1
Dec 16, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.47
CADD
Benign
12
DANN
Benign
0.63
PhyloP100
1.5
Mutation Taster
=95/5
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.080
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41285476; hg19: chr14-67610127; COSMIC: COSV59478061; API